Dr. Ashish  Baldi
My Social Links

Dr. Ashish Baldi

Dean
Maharaja Ranjit Singh Punjab Technical University, India


Highest Degree
Ph.D. in Pharmaceutical Sciences from Maharaja Ranjit Singh Punjab Technical University, India

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Pharmaceutical Analysis
62%
Biotechnology
90%
Pharmaceutical Biology
75%
Biotechnology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Sharma, N. and A. Baldi, 2016. Exploring versatile applications of cyclodextrins: An overview. Drug delivery, 23: 729-747.
    CrossRef  |  Direct Link  |  
  2. Kumar, B. and A. Baldi, 2016. The challenge of counterfeit drugs: A comprehensive review on prevalence, detection and preventive measures. Curr. Drug Saf., 11: 112-120.
    Direct Link  |  
  3. Kamaljeet and A. Baldi, 2016. Personalized Medicines: The Futuristic Treatment Approach. In: Integration of Life and Medical Sciences, Bansal, P. (Ed.). Adbi Parwaz Publications, India, ISBN: 978-93-85404-33-7, pp: 186-206.
  4. Arora, D., B. Arora and A. Baldi, 2016. Nanomedicines: An Overview. In: Integration of Life and Medical Sciences, Bansal, P. (Ed.). Gulab Publishers, India, ISBN: 978-93-85404-33-7, pp. 186-206.
  5. Ali, Z., N. Mishra and A. Baldi, 2016. Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria. Artif. Cell Nanomed. Biotechnol., 44: 545-549.
    CrossRef  |  Direct Link  |  
  6. Sharma, K. and K. Jeet and A. Baldi, 2015. Management of acute mountain sickness: An exploratory review on herbal d rugs. Indian J. Nat. Prod., 29: 5-94.
    Direct Link  |  
  7. Kumar, S., K. Jeet and B. Ashish, 2015. Recent technological advancements in multiparticulate formulations: The smart drug delivery systems. Asian J. Pharm., 9: S13-S25.
  8. Kumar, S. and A. Baldi, 2015. Formulation by design approach for fizzy granules using statistical optimization methodologies. Asian J. Pharm. 9: S59-S67.
  9. Kumar, D., M. Arora and A. Baldi, 2015. Understanding industrial practices for pharmaceutical quality management-I, existing approaches and guidelines. Adv. Res. Pharm. Biol., 5: 802-811.
  10. Kumar, B. and A. Baldi, 2015. Understanding industrial practices for pharmaceutical quality management-II, Process validation. Adv. Res. Pharm. Biol., 5: 812-824.
  11. Kamal, J. and A. Baldi, 2015. Approaches to overcome NSAID induced ulceration in arthritic pain management: Perspectives and prospects. J. Drug Delivery Ther., 5: 9-16.
  12. Baldi, A., M.S. Panwar and S. Goyal, 2015. Development and validation of spectrophotometric method for determination of ropinirole hydrochloride in bulk and formulation. Inv. Rapid Pharm. Analysis Q. Assur., 2015: 1-4.
    Direct Link  |  
  13. Arora, M., S. Sharma and A. Baldi, 2015. Regulatory categories of probiotics across the globe: A review representing existing and recommended categorization. Indian J. Med. Microbiol., 33: 2-10.
    CrossRef  |  Direct Link  |  
  14. Arora, M., A. Baldi and D. Singh, 2015. Existing Regulatory Regimes for Traditional Products with Health Claims: Insights and Prospects. In: Potentials and Bottlenecks in Clinical Trials of Herbal Drugs, Bansal, P. and S.E. Reddy (Eds.). Gulab Publishers, India, ISBN: 978-81-920643-9-0, pp: 32-50.
  15. Arora, M. and A. Baldi, 2015. Regulatory categories of probiotics across the globe: A review representing existing and recommended categorization. Indian J. Med. Microbial., 33: 2-10.
    Direct Link  |  
  16. Arora, M. and A. Baldi, 2015. Good manufacturing practice regulations for probiotic based pharmaceuticals: Current scenario and suggestive recommendations. Applied Clin. Res. Clin. Trial Regul. Affairs, 2: 165-175.
    Direct Link  |  
  17. Arora, M. and A. Baldi, 2015. Comparative account of quality management and regulatory aspects of products with health claims: Existing approaches and future challenges for probiotics and herbal products. Applied Clin. Res. Clin. Tria. Regul. Affair, 2: 123-132.
    Direct Link  |  
  18. Mishra, N., D. Singh, S. Sharma and A. Baldi, 2014. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery. Curr. Drug Delivery, 11: 729-743.
    Direct Link  |  
  19. Bhandari, S. and A. Baldi, 2014. Total quality management of pharmaceuticals: Recent approaches and advancements. Adv. Res. Pharm. Biol., 4: 655-663.
  20. Thakur, S., S. Sharma, S. Kumar, U. Singh and A. Baldi, 2013. Artemisinin: The ‘Molecule of Hope’ for treatment of malaria. Pharm. Aspire, 4: 84-89.
  21. Singh, U. and A. Baldi, 2013. Simultaneous estimation of quercetin and silymarin: Method development and validation. Int. J. Pharm. Biol. Archive, 4: 527-531.
  22. Sharma, S., M. Arora and A. Baldi, 2013. Probiotics in India: Current status and future prospects. Pharm. Aspire, 4: 68-77.
  23. Sharma, P., D. Joshi, A. Baldi, K. Khatri and D. Dubey, 2013. White tea: Offering something new to your health. Pharm. Aspire, 4: 54-60.
  24. Kumar, S. and A. Baldi, 2013. Pharmacovigilance in India: Perspectives and prospects. J. Drug Delivery Ther., 3: 237-246.
  25. Kumar, S. and A. Baldi, 2013. Pharmacoeconomics: Principles, methods and economic evaluation of drug therapies. Pharm. Tech. Med., 2: 362-369.
  26. Kumar, S. and A. Baldi, 2013. Design of experiment based statistical optimization in life science research: An overview. Pharm. Aspire, 4: 35-43.
  27. Baldi, A., N. Choudhary and S. Kumar, 2013. Nutraceuticals as therapeutic agents for holistic treatment of diabetes. Int. J. Green Pharm., 7: 278-287.
    CrossRef  |  Direct Link  |  
  28. Baldi, A. and S. Kumar, 2013. Water for Pharmaceutical Uses: Quality Control and Validation. In: Water for Health, Gill, S.S., P. Bansal and R. Manhas (Eds.). Basera Verlag, Munchen, Germany, pp: 236-255.
  29. Baldi, A. and N. Choudhary, 2013. In vitro antioxidant and hepatoprotective potential of Chenopodium album extract. Int. J. Green Pharm., 7: 50-56.
    CrossRef  |  Direct Link  |  
  30. Arora, M., S. Sharma and A. Baldi, 2013. Comparative insight of regulatory guidelines for probiotics in USA, India and Malaysia: A critical review. Int. J. Biotechnol. Well. Ind., 2: 51-64.
    CrossRef  |  Direct Link  |  
  31. Sumit, K., T. Shikha, T. Deepika and B. Ashish, 2012. A quantitative approach for pharmaceutical quality by design patterns. Inveti Rapid Pharm. Analysis Q. Assur., 2012: 1-8.
  32. Sumit, K., S. Vivek, S. Sujata and B. Ashish, 2012. Herbal cosmetics: Used for skin and hair. Inven. J., 2012: 1-7.
  33. Baldi, A., M. Pandit and P. Ranka, 2012. Amelioration of in vivo antioxidant activity of banana extracts. IJPBA, 3: 157-161.
  34. Saini, K., N. Saini and A. Baldi, 2011. Impact of anti-counterfeiting trade agreement on pharma sector: A global perspective. J. Curr. Pharm. Res., 6: 4-10.
  35. Baldi, A., M.S. Panwar and R. Gupta, 2011. Evaluation of in vitro antioxidant activity of Eclipta alba. Int. J. Pharma. Biol. Arch., 2: 767-771.
  36. Baldi, A. and S. Goyal, 2011. Hypoglycemic effect of polyherbal formulation in alloxan induced diabetic rats. Pharmacologyonline, 3: 764-773.
    Direct Link  |  
  37. Bagherwal, A., A. Baldi, R.K. Nagar and D.K. Patidar, 2011. Synthesis and antimicrobial studies of azetidinone derivatives from naphthylamine moiety. Synthesis, 3: 274-279.
  38. Farkya, S., A. Baldi, V. Kumar, V. Datta and R. Mehra et al., 2010. Impact of symbiotic fungi on production of secondary metabolites by plant cell culture, Asia Pacific. J. Mol. Biol. Biotechnol., 18: 51-53.
  39. Baldim, A., D. Goyal, M. Choudhary and A. Mobiya, 2010. Effect of Chenopodium album extract in paracetamol induced hepatotoxicity in rats. Int. J. Pharm. Sci. Biotech., 1: 223-227.
  40. Baldi, A., W. Hussain and Y. Tailor, 2010. Evaluation of in-vitro cultured cells of Withania somniferafor antioxidant activity. Curr. Trend Biotechnol. Pharm., 4: 589-595.
  41. Baldi, A., S. Farakya, A. Jain, N. Gupta and R. Mehra et al., 2010. Enhanced production of podophyllotoxins by co-culture of transformed Linum album cells with plant growth promoting fungi. Pure Applied Chem., 82: 227-241.
  42. Baldi, A., N. Choudhary, J. Maru and R. Joshi, 2010. Effect of pumpkin concentrate on alloxan induced diabetic rats. J. Global Pharma Technol., 2: 24-27.
  43. Baldi, A., A.K. Patidar and J. Sanadya, 2010. Method development and validation for estimation of quetiapine fumarate by RP-HPLC. Asian J. Res. Chem., 3: 604-607.
    Direct Link  |  
  44. Baldi, A., 2010. Computational approaches for drug design and discovery: An overview. Syst. Rev. Pharm., 1: 99-105.
    CrossRef  |  Direct Link  |  
  45. Baldi, A., A.K. Srivastava and V.S. Bisaria, 2009. Fungal Elicitors for Enhanced Production of Secondary Metabolites in Plant Cell Suspension Cultures. In: Symbiotic Fungi, Varma, A.K. and A.C. Kharkwal (Eds.). Springer-Verlag, Heidelburg, ISBN: 978-3-540-95893-2, pp: 373-380.
  46. Baldi, A., A. Jain, N. Gupta, A.K. Srivastava and V.S. Bisaria, 2009. Coculture of Linum album Cells and Piriformospora indica for Improved Production of Phytopharmaceuticals. In: Symbiotic Fungi, Varma, A.K. and A.C. Kharkwal (Eds.). Springer-Verlag, Heidelburg, ISBN: 978-3-540-95893-2, pp: 361-372.
  47. Baldi, A., 2009. Erectile dysfunction and ayurveda. J. Res. Educ. Indian Med., 14: 15-24.
  48. Ashish, B. and T. Yogendra, 2009. Pharmacogenomics and its impact on drug discovery. J. Global Pharm. Technol., 1: 26-36.
  49. Bisaria, V.S., A. Baldi, V. Kumar, N. Gupta, A. Jain, S. Farkya and A.K. Srivastava, 2008. Interaction of phytopromotional fungi and plant cells on synthesis of plant-derived metabolites. J. Biotechnol., 136: S11-S11.
    CrossRef  |  Direct Link  |  
  50. Baldi, A., V.S. Bisaria and A.K. Srivastava, 2008. Biotechnological Approaches for Production of Some Plant based Chemotherapeutics. In: Medicinal Plant Biotechnology, Kayser, O. and W.J. Quax (Eds.). Wiley-VCH Verlag, Germany, ISBN: 978-3-527-31443-0, pp: 117-156.
  51. Baldi, A., D. Singh and V.K. Dixit, 2008. Dual elicitation for improved production of withaferin a by cell suspension cultures of Withania somnifera. Applied Biochem. Biotechnol., 151: 556-564.
    Direct Link  |  
  52. Baldi, A., A.K. Srivastava and V.S. Bisaria, 2008. Improved podophyllotoxin production by transformed cultures of Linum album. Biotechnol. J., 3: 1256-1263.
    CrossRef  |  Direct Link  |  
  53. Baldi, A., A.K. Srivastava and V.S. Bisaria, 2008. Effect of aeration on production of anticancer lignans by cell suspension cultures of Linum album. Applied Biochem. Biotechnol., 151: 547-555.
    Direct Link  |  
  54. Baldi, A., A. Jain, N. Gupta, A.K. Srivastava and V.S. Bisaria, 2008. Co-culture of arbuscular mycorrhiza-like fungi (Piriformospora indica and Sebacina vermifera) with plant cells of Linum album for enhanced production of podophyllotoxins: A first report. Biotechnol. Lett., 30: 1671-1677.
    Direct Link  |  
  55. Baldi, A. and V.K. Dixit, 2008. Enhanced production of artemisinin by cell cultures of Artemisia annua. Curr. Trend Biotechnol. Pharm., 2: 341-348.
  56. Baldi, A. and V. Dixit, 2008. Yield enhancement strategies for artemisinin production by suspension cultures of Artemisia annua. Bioresour. Technol., 99: 4609-4614.
    CrossRef  |  Direct Link  |  
  57. Baldi, A., S. Saraf and S. Saraf, 2007. Garlic: A better substitute for Viagra. Sanjeevani Med. Times, 4: 66-68.
  58. Baldi, A., 2007. Medical tourism in India: Opportunities unlimited, Sanjeevani Med. Times, 10: 70-75.
  59. Baldi, A., 2007. Erectile dysfunction and its treatment. Sanjeevani Med. Times, 4: 34-37.
  60. Baldi, A., 2006. Drug discovery and computer aided drug design. JNPA, 24: 1-16.
  61. Baldi, A. and V.K. Dixit, 2006. Enhanced production of artemisinin by hairy root cultures of Artemisia annua L. JNPA, 24: 27-38.
  62. Baldi, A., R.S. Pandey and J. Madan, 2002. Parkinsonism: History and novel biotech approach. J. Sci. Pharm., 3: 62-65.
  63. Baldi, A., S. Saraf and S. Saraf, 2001. Viagra and garlic: A comparative study. Eastern Pharmacist, 44: 35-38.